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Background: This study was designed to determine relationship between the glucose metabolism disorder (the
insulin resistance and the impaired glucose tolerance) and α-thalassemia.
Methods: In this historical cohort study, 80Alpha-thalassemia carriers and 80 healthy people were enrolled. The
participants had no diabetes familial history and the waist circumference and blood pressure were in normal range
(waist circumference of less than 102 cm in men, 88 cm in women and blood pressure <120/80 mmHg). The serum
insulin level, fasting blood glucose (after 12 hours fasting) and two-hour plasma glucose during an oral glucose
tolerance test (2-h OGTT) were measured. Insulin resistance was estimated according to homeostasis model
assessment method (HOMA). Chi-square test, independent sample t-test and the relative risk were used for data
analysis.
Results: According to FBS and OGTT results, the percentage of diabetes mellitus and pre-diabetes were 1.3% and
33.8% in Alpha-thalassemia carriers, respectively. The control group showed 2.5% diabetic and 13.8% pre-diabetic
cases as well. The relative risk for the glucose tolerance impairment (diabetes and pre-diabetes) was 2.78 (95% CI:
1.31-5.88, P = 0.07).Six and a half percent of the Alpha-thalassemia group and 2.5% in the control group had 2.25 ≤
HOMAIR ≤ 3.59 (an intermediate state of Insulin sensitivity) p = 0.443. In the study, there was no subject with insulin
resistance (HOMAIR >3.59).
Conclusions: The possibility of risk enhancement of the impaired glucose tolerance (pre-diabetes and diabetes
mellitus) in patients with α-thalassemia is almost three times greater than the normal population without
relationship with insulin resistance. Diabetic and pre-diabetic Alpha-thalassemia carrier state is younger than the
general population suffering of these disorders.
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The insulin resistance was reported in association with
hemoglobinopathies [1]. An iron overload and a depos-
ition in the liver and also the pancreatic β cells damage
are considered as the causes of the impaired glucose tol-
erance in patients who need frequent blood transfusions
[1,2]. In addition,the iron turnover due to the hemolysis
of the microcytic erythrocytes can result in the oxidative
stress and the insulin resistance [3]. A positive relation-
ship between the oxidative stress, the iron overload and
the insulin resistance was observed in beta- thalasseamia
major patients [4]. The prevalence of the impaired* Correspondence: kashi_zahra@yahoo.com
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unless otherwise stated.glucose tolerance and the diabetes mellitus in this group
were reported 4-24% and 0-26% respectively [5] in line
with serum ferritin concentration [6]. The insulin resist-
ance can be seen in minor thalassemia without impair-
ment glucose tolerance [7]. A retrospective study on
1,861 patients with thalassemia major (1954–1998)
showed a decrease in the prevalence of the glucose me-
tabolism disorders and an increase in the mean age at the
diagnosis of diabetes over the years. Early treatment with
the iron chelators was proposed as the cause of this de-
cline [8]. In our pervious study on 164 patients including
82 β-thalassemia traits and 82 normal cases,we showed
that the prevalence of IGT (Impaired Glucose Tolerance)
and diabetes were higher in patients with thalassemia
minor than the normal subjects and the risk of diabeteshis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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prevalence of diabetes and glucose intolerance in patients
with thalassemia major and minor was reported greater
than the normal people in another study as well [10].
The number of studies on the α-thalassemia trait and
the glucose impaired metabolism is scanty. In a study
carried out in 1996, the incidence of Gestational Diabetes
Mellitus (GDM) was doubled in women with α-
thalassemia trait(s) than women with the iron deficiency
anemia [11]. Lao and L.F (2001) stated that the alpha-
thalassemia trait was an important factor in the diagnosis
of the gestational diabetes (OR 11.74, 95% CI 6.37-21.63)
[12]. Given the extent of the α-thalassemia disease in the
north part of Iran and the possibility of the impaired glu-
cose metabolism in these subjects and also the lack of ad-
equate research in this area, the study was an attempt to
investigate the relationship between the glucose metabol-
ism disorder (the insulin resistance and the impaired glu-
cose tolerance) and α-thalassemia.
Materials and methods
After obtaining the ethical board committee of Mazan-
daran University of Medical Sciences approval, this his-
torical cohort study examined, 80 α-thalassaemia trait
cases (hypo chromic microcytic anemia, without an iron
deficiency anemia and a normal hemoglobin electrophor-
esis) referred to the Mazandaran thalassaemia Centre
and also related to the hematology clinic in Sari, the cap-
ital of Mazandaran province in the north part of Iran
were enrolled. The control group consisted of 80 normal
subjects referring to the same clinics for a routine evalu-
ation and they were negative about α-thalassaemia. The
sampling method was Judgmental or a purposive sam-
pling. The study period was from April until March
2011–2012. The inclusion criteria were summarized as
follows:
1. Age range between 20 and 60.
2. Without history of kidney, liver and heart diseases,
(such as advanced liver, renal and heart failure).
3. Not taking medicine that affects the glucose
tolerance (such as steroids, second- generation
antipsychotic).
4. No history of diabetes mellitus.
5. No history of diabetes in parents and/or siblings.
6. Having a normal blood pressure (systolic blood
pressure <120 and diastolic blood pressure
<80 mmHg).
7. Waist circumference of less than 102 cm in men
and 88 cm in women (according to the 2001 IDF,
NCEP: ATPIII criteria) [13].
The weight of participants was measured with a digital
scale (Microlife ws80 Switzerland), ±100 gr accuracywithout shoes and excess clothing. The height was mea-
sured in straight position without shoes by a ruler (with
a precision of 1 mm), while the back of head, thoracic
spine, buttocks, and heels (qua were together) touched
the wall.
The BMI (body mass index) was calculated by dividing
the weight in kg by the square of height in meters (kg/
m2). The waist circumference was measured with a flex-
ible tape placed on a horizontal plane at the level of the
iliac crest (with an accuracy of 1 mm).
The Venous blood samples for the laboratory studies
(FBS, AST, ALT, hsCRP, serum insulin level, and after fast-
ing for 12 hrs) were collected from both groups. A stand-
ard oral glucose tolerance test (OGTT) with 75 g glucose
was done in two study groups. In both groups, participants
with abnormal FBS and BS2hpG (FBS from 100 to 125 and
BS2hpp ≥ 140-199) were re-tested for FBS and BS2hpG.
Serum FBS was analyzed by enzymatic calorimetric
method using the glucose kit of Parsazmoon Co, Iran. AST
(Aspartate amino transferase) and ALT (Alanine amino-
transferase) were measured by calorimetric method using
Biosystem kit, Spain and Hitachi917, Germany. The high
sensitive C-reactive protein (hs-CRP) was measured by
imminotorbidometry assay by Pars Azmoon kit, England,
using Hitachi917 machine Germany. ELISA test with
Hitachi auto analyzer using Monobind kit, USA was used
to assess serum insulin levels.
Insulin resistance was estimated after measuring the
level of fasting blood sugar (glucose oxidase method
using enzymatic colorimetric glucose kits, Pars, Iran) and
serum insulin by the HOMAIR formula (HOMA: Homeo-
stasis model assessment method) were calculated.
HOMAIR ¼ Fasting plasma insulin mIU=1ð Þ
 Fasting plasma glucose mmo=1ð Þ=22:5
The participants were divided into three following
categories:
1. HOMAIR < 2.24 as a sensitive one to insulin (insulin
sensitive)
2. 2.24 ≤HOMAIR ≤ 3.59 as an intermediate state
(Intermediate)
3. HOMAIR > 3.59 as an insulin resistant [1]
The data was analyzed by using SPSS software. The
mean standard deviation (SD), mode and percentiles
were used for the purpose of descriptive analysis. The
demographic and clinical characteristics were described
as a proportion and a mean ± SD. The data analysis was
performed by the Independent Student Sample t-test to
compare the quantitative variables and the Chi-square
test to compare the qualitative ones between the two
groups. In addition, the relative risk was calculated.
Table 2 The Distribution of some laboratory tests in the
α-thalassemia and controls
Case (n = 80) Control (n = 80) P-value*
Mean 95% CI Mean 95% CI
AST (mg/dL) 22 20.5 - 23.4 24.8 23.6 -26.0 0.004
ALT (mg/dL) 19.8 18.0 - 21.6 19.6 17.9 - 21.2 0.831
Haemoglobin 11.9 11.5 - 12.3 13.8 13.6 -14.1 <0.0001**
MCV 73.1 71.8 - 74.4 87.1 86.5 - 87.8 <0.0001
Ferritin 129.1 90.3 - 167.8 85.3 77.4 - 93.3 0.029**
hsCRP 2.66 2.14 - 3.17 2.43 2.12 - 2.74 0.46
*Independent Student t-test.
**the difference was significant after considering the age and gender as
covariates in the comparison two groups by ANCOVA test.
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cant level . The normal distribution of variables was con-
firmed by One-Sample Kolmogorov-Smirnov Test.
Results
160 subjects in this study were studied. Out of 80 Alpha-
thalassemia carriers state, 30 subjects (37.5%) were male
and the rest were female and in the control group, both
males and females consisted 40 cases (50%). (p = 0.11).
These two groups were matched for age, waist circum-
ference, and blood pressure. The mean of the waist cir-
cumference in Alpha-thalassemia group was 87.1 cm
(95% CI: 85.5 to 88.6) while in the control group, it was
88 cm (95% CI: 86.3 to 89.7), (p = 0.41), (the demographic
characteristics are shown in Table 1). The mean age of
subjects in the study was 32.5 ± 9.9 years, ranged between
20 to 58 and 20 to 55 in years old the Alpha-thalassemia
and control groups respectively. The variables showed
significant differences for AST, Hb, MCV and ferritin be-
tween two groups (see Table 2).
The mean of fasting blood sugar (FBS) in the main group
(93.7 ± 12.3 mg/dl) was higher than that in the control
group (86.9 ± 12.4) (p = 0.001). The average blood sugar
after OGTT (75 gr oral glucose) was 97.7 ± 25.6 mg/dl,
whereas it was approximately 91.8 ± 23.6 mg/dl in the con-
trol group (p = 0.133). The mean of fasting insulin levels
was 4.80 micIU/ml (95% CI: 4.28 - 5.33) and 4.77
micIU/ml (95% CI: 4.30 - 5.24) in the main and control
group respectively (p = 0.924). The mean of HOMAIR-
was1.13 ± 0.62 in cases and 1.013 ± 0.50 in the controls
(p = 0.283) .
27 cases (33.8%) and 11 (13.8%) of the controls had
IFG or IGT (pre-diabetic state). The risk of the pre-
diabetes state was 3.16(95% CI: 1.44-6.69, P = 0.003) in
α-thalassemia patients. One person (1.3%) in the case
group and 2 people (2.5%) in the control group were di-
agnosed as a diabetic case (see Figure 1). The relative
risk of the glucose tolerance impairment state (pre-dia-
betes or diabetes mellitus) was 2.78 (95% CI: 1.31 -
5.88), (p = 0.007) in the α-thalassemia compared to the
control and the α-thalassemia carrier state patients wereTable 1 The Demographic characteristics in the exposure
group (α-thalassemia) and people without exposure
Case (n = 80) Control (n = 80) P-value*
Mean 95% CI Mean 95% CI
Age (Years) 33.2 30.9-35.5 31.8 29.7-33.9 0.354
Waist Circumference
(cm)
87.1 85.5-88.6 88 86.3-89.7 0.414
Systolic Blood
Pressure (MmHg)
112.6 111.1-114.1 111.2 109.7-112.7 0.182
Diastolic Blood
Pressure (MmHg)
74.3 73.1-75.4 75.3 74.4-76.2 0.154
* Independent Student t-test.almost 3 times more at risk of impaired glucose toler-
ance (pre-diabetes and diabetes mellitus) than the
normal state.
AST levels in the case sand control were 22 IU/L(95%
CI: 20.5 - 23.4) and 24.8 IU/L (95% CI: 23.6 -26) respect-
ively, (p = 0.004). Although the level of ALT and CRP
were not significantly different between two groups,
there was a positive correlation between hsCRP and
ALT as well as ferritin (r = 0.3, p = 0.03 and r = 0.4, p =
0.001 respectively) only in alpha thalassemia group (see
Table 2). According to HOMA-IR method, 6.5 percent-
age of main group and 2.5% of control was considered
as intermediate state, (p = 0.443). No subject with insulin
resistance was observed .there were no subject with in-
sulin resistance (HOMAIR >3.59). 18 out of 27 patients
(66.7%) with pre-diabetes state in Alpha-thalassemia car-
riers and 7 out of 11 pre-diabetic persons in the control
group (63.6%) were less than 40 years old (p = 0.011).
Discussion
The results show that the risk of the impaired glucose
tolerance state (pre-diabetes or diabetes) is higher in the
α-thalassaemia than the normal population, 2.78 (95%
CI: 1.31 - 5.88), (p = 0.007) and the patients with α-
thalassemia are almost three times more at risk. In a
study conducted in Hong Kong by Lao and HO in 1996
on women with anaemia during pregnancy and its out-
come, they found out that the incidence of the gestational
diabetes in women with the α-thalassaemia trait doubled
compared to the iron deficient pregnant women [11].
Lao and HO (2001) did another study on the pregnant
women. 163 α-thalassaemia trait pregnant cases were ex-
amined. According to the results of oral glucose toler-
ance test (OGTT), the glucose tolerance was impaired in
62% of the α-thalassaemia Trait group and 14.7% of con-
trol group [12]. In present study, the prevalence rate of
the impaired glucose tolerance (pre-diabetes and dia-
betes mellitus) in non-pregnant women with the age
groups of 20 to 60 years was 35% and 16.3% in the α-
Figure 1 The proportion of diabetes or pre-diabetes in the exposure group (α-thalassemia) and people without exposure
(Pvalue = 0.007,Chi-square test).
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probability of diabetes and pre-diabetes state was 2.78
times in the α-thalassaemia group compared to the con-
trol. The prevalence of diabetes in alfathalassaemia was
1.3 percent which was considerably lower than the previ-
ous our pervious study on beta thalassaemia, 8.5% [9]. In
contrast, the prevalence of pre-diabetic in α-thalassemia
in the present study was 33.8% which was higher than
the pre-diabetic prevalence in β-thalassaemia minor pa-
tients, 12.2% [9]. Perhaps a higher prevalence of diabetes
than pre-diabetes in β-thalassemia is due to more
hemolysis resulting in more inflammation of the liver in
β-thalassaemia than α-thalassaemia. In both studies on
alpha and beta thalassemia carrier state, pre-diabetes
condition was higher than the normal population. In this
study, the difference between the two groups (alpha
thlassaemia and the normal individuals) based on fasting
insulin levels and HOMAIR, was not statistically signifi-
cant but in beta thalassaemia minor study, two patients
(2.4%) in the case group and no patient in control (0%)
had an insulin resistance. In a study on 17 normal glu-
cose tolerance beta thalassaemia minor trait patients by
Tong and colleagues (2002), fasting insulin levels were
higher than control (p = 0.003) and the insulin resistance
state was higher in the thalassemia trait group too (p =
0.004) [7]. The difference between these studies is some
extent due to the size of the waist circumferences and
exclusion of the cases with high waist circumferences
and also cases at risk of metabolic syndrome in this
study. The multiple research showed the correlation of
liver inflammation and serum level of ALT,AST, ALP
and Gamma glutamyltransferase (GGT) and also insulin
resistance [4,6,14]. In Simvax study the oxidant stressand modulation of adipokines and intracellular signal
transduction pathways were suggested as underlying mo-
lecular mechanisms of iron and diabetes risk [15]. In
present study,there was a positive correlation between
hsCRP and ALT as well as ferritin only in alpha thalas-
semia group but we didn’t find any relationship between
insulin resistance and ALT, CRP and ferritin. Maybe
there are other pathways which affect the glucose
homeostasis in individuals with alpha thalassemia how-
ever, they are not still established and further research is
required. Diabetic and pre-diabetic Alpha-thalassemia
carriers are younger than the general population suffer-
ing from these disorders. Though the failure to identify
significant difference between the HOMR-IR between
the two groups in our study may be related to sample
size, it seems that the higher risk of the impaired glucose
condition in alpha-thalassemia carriers state is not dir-
ectly due to the insulin resistance and the mechanism of
the disorder should be taken into consideration.
The limitation of the study was duo to the lack of
evaluation of the GGT serum level and oxidative stress
and other specific inflammatory markers.
Conclusion
Given the high prevalence of α-thalassaemia in the north
part of Iran and risk enhancement of the impaired glu-
cose tolerance in this group, it is recommended that the
α-thalassaemia state should be considered as one of the
diabetes risk factors. It is also advised that this group is
screened for IGT and diabetes at younger age compared
to the normal population in order to detect the disease
as early as possible and also to take the preventive
interventions.
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sample size is done to compare the inflammatory fac-
tors, the oxidative stress markers and the haemolysis sta-
tus between α-thalassemia and β-thalassaemia.
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